Compound 699
Identifiers
- Canonical SMILES:
C[C@@](O)(c1ccc(Cl)cc1)c1ccc(Cl)c(CCOc2ccc(cc2)-c2ccc(cc2)C(O)=O)c1
- IUPAC name:
4-[4-[2-[2-chloro-5-[1-(4-chlorophenyl)-1-hydroxyethyl]phenyl]ethoxy]phenyl]benzoic acid
- InChi:
InChI=1S/C29H24Cl2O4/c1-29(34,23-8-11-25(30)12-9-23)24-10-15-27(31)22(18-24)16-17-35-26-13-6-20(7-14-26)19-2-4-21(5-3-19)28(32)33/h2-15,18,34H,16-17H2,1H3,(H,32,33)/t29-/m1/s1
- InChiKey:
SNNAEGQGFRLGPM-GDLZYMKVSA-N
External links
168318133 |
26361840 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 6.34 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 506.11 g/mol | |||
HBA | 4 | |||
HBD | 2 | |||
HBA + HBD | 6 | |||
AlogP | 7.50 | |||
TPSA | 66.76 | |||
RB | 8 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5790 | Fenofibric acid | DB13873 | |
0.5700 | Fenofibrate | DB01039 | |
0.5098 | (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid | DB08121 | |
0.5091 | 4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN | DB04696 | |
0.5089 | LY-2300559 | DB13016 | |
0.5050 | 2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID | DB07047 | |
0.5040 | Dapagliflozin | DB06292 | |
0.5038 | Empagliflozin | DB09038 | |
0.4961 | Bexagliflozin | DB12236 | |
0.4950 | (3-Chloro-4-Propoxy-Phenyl)-Acetic Acid | DB02773 | |
0.4906 | Adapalene | DB00210 | |
0.4904 | (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid | DB08760 | |
0.4757 | Lifibrol | DB12448 | |
0.4688 | Carisbamate | DB12338 | |
0.4519 | Alclofenac | DB13167 |